Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Noah Hahn, M.D.
Hoosier Cancer Research Network
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama Hematology Oncology Clinic at Medical West
Birmingham, Alabama, United States
- City of Hope: Duarte
Duarte, California, United States
- City of Hope: Antelope Valley
Lancaster, California, United States
- Ucla: Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
- Usc: Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Iu Health Goshen Hospital
Goshen, Indiana, United States
- Iu Health Central Indiana Cancer Centers
Indianapolis, Indiana, United States
- Indiana University Melvin & Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Iu Health at Ball Memorial Hospital
Muncie, Indiana, United States
- Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, United States
- University of Maryland: Greenebaum Cancer Center
Baltimore, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- University of Michigan Cancer Center
Ann Arbor, Michigan, United States
- Siteman Cancer Center
St Louis, Missouri, United States
- Nebraska Cancer Specialists
Omaha, Nebraska, United States
- Dartmouth-Hitchcock Medical Center: Norris Cotton Cancer Center
Manchester, New Hampshire, United States
- Memorial Sloan-Kettering Cancer Center: Basking Ridge
Basking Ridge, New Jersey, United States
- John Theurer Cancer Center: Hackensack University Medical Center
Hackensack, New Jersey, United States
- Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- University of New Mexico Cancer Center: Albuquerque
Albuquerque, New Mexico, United States
- University of New Mexico Cancer Center: Las Cruces
Las Cruces, New Mexico, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Memorial Sloan-Kettering Cancer Center: Commack
Commack, New York, United States
- Memorial Sloan-Kettering Cancer Center: Main Campus
New York, New York, United States
- New York University Clinical Cancer Center
New York, New York, United States
- University of Rochester Medical Center
Rochester, New York, United States
- Memorial Sloan-Kettering Cancer Center: Rockville Centre
Rockville Centre, New York, United States
- Memorial Sloan-Kettering Cancer Center: Sleepy Hollow
Sleepy Hollow, New York, United States
- Cleveland Clinic: Taussig Cancer Institute
Cleveland, Ohio, United States
- University Hospitals Seidman Cancer Center
Cleveland, Ohio, United States
- Lake Health: University Hospitals Seidman Cancer Center
Mentor, Ohio, United States
- Uhhs Chagrin Highlands: Seidman Cancer Center
Orange, Ohio, United States
- Thomas Jefferson University: Kimmel Cancer Center
Philadelphia, Pennsylvania, United States
- Musc Hollings Cancer Center
Charleston, South Carolina, United States
- Froedtert & Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2013
- Primary completion
- 31 Oct 2017
- Completion
- 31 Oct 2017
- Last update posted
- 11 Jul 2022
- Registered enrollment
- 200
- Registry id
- NCT01780545
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.